IBDEI13E ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18568,0)
 ;;=J10.1^^79^880^53
 ;;^UTILITY(U,$J,358.3,18568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18568,1,3,0)
 ;;=3^Flu d/t Indentified Flu Virus w/ Respiratory Manifestations
 ;;^UTILITY(U,$J,358.3,18568,1,4,0)
 ;;=4^J10.1
 ;;^UTILITY(U,$J,358.3,18568,2)
 ;;=^5008151
 ;;^UTILITY(U,$J,358.3,18569,0)
 ;;=J11.1^^79^880^54
 ;;^UTILITY(U,$J,358.3,18569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18569,1,3,0)
 ;;=3^Flu d/t Unidentified Flu Virus w/ Respiratory Manifestations NEC
 ;;^UTILITY(U,$J,358.3,18569,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,18569,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,18570,0)
 ;;=K52.9^^79^880^80
 ;;^UTILITY(U,$J,358.3,18570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18570,1,3,0)
 ;;=3^Noninfective Gastroenteritis/Colitis,Unspec
 ;;^UTILITY(U,$J,358.3,18570,1,4,0)
 ;;=4^K52.9
 ;;^UTILITY(U,$J,358.3,18570,2)
 ;;=^5008704
 ;;^UTILITY(U,$J,358.3,18571,0)
 ;;=K52.89^^79^880^79
 ;;^UTILITY(U,$J,358.3,18571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18571,1,3,0)
 ;;=3^Noninfective Gastroenteritis/Colitis NEC
 ;;^UTILITY(U,$J,358.3,18571,1,4,0)
 ;;=4^K52.89
 ;;^UTILITY(U,$J,358.3,18571,2)
 ;;=^5008703
 ;;^UTILITY(U,$J,358.3,18572,0)
 ;;=K57.32^^79^880^46
 ;;^UTILITY(U,$J,358.3,18572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18572,1,3,0)
 ;;=3^Diverticulitis of Lg Intestine w/o Perforation/Abscess w/o Bleeding
 ;;^UTILITY(U,$J,358.3,18572,1,4,0)
 ;;=4^K57.32
 ;;^UTILITY(U,$J,358.3,18572,2)
 ;;=^5008725
 ;;^UTILITY(U,$J,358.3,18573,0)
 ;;=K70.10^^79^880^13
 ;;^UTILITY(U,$J,358.3,18573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18573,1,3,0)
 ;;=3^Alcoholic Hepatitis w/o Ascites
 ;;^UTILITY(U,$J,358.3,18573,1,4,0)
 ;;=4^K70.10
 ;;^UTILITY(U,$J,358.3,18573,2)
 ;;=^5008785
 ;;^UTILITY(U,$J,358.3,18574,0)
 ;;=K73.0^^79^880^34
 ;;^UTILITY(U,$J,358.3,18574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18574,1,3,0)
 ;;=3^Chronic Persistent Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,18574,1,4,0)
 ;;=4^K73.0
 ;;^UTILITY(U,$J,358.3,18574,2)
 ;;=^5008811
 ;;^UTILITY(U,$J,358.3,18575,0)
 ;;=N12.^^79^880^104
 ;;^UTILITY(U,$J,358.3,18575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18575,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,18575,1,4,0)
 ;;=4^N12.
 ;;^UTILITY(U,$J,358.3,18575,2)
 ;;=^5015575
 ;;^UTILITY(U,$J,358.3,18576,0)
 ;;=N30.90^^79^880^42
 ;;^UTILITY(U,$J,358.3,18576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18576,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,18576,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,18576,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,18577,0)
 ;;=N30.91^^79^880^41
 ;;^UTILITY(U,$J,358.3,18577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18577,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,18577,1,4,0)
 ;;=4^N30.91
 ;;^UTILITY(U,$J,358.3,18577,2)
 ;;=^5015643
 ;;^UTILITY(U,$J,358.3,18578,0)
 ;;=N70.92^^79^880^81
 ;;^UTILITY(U,$J,358.3,18578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18578,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,18578,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,18578,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,18579,0)
 ;;=N73.9^^79^880^51
 ;;^UTILITY(U,$J,358.3,18579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18579,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18579,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,18579,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,18580,0)
 ;;=N72.^^79^880^69
 ;;^UTILITY(U,$J,358.3,18580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18580,1,3,0)
 ;;=3^Inflammatory Disease of Cervix Uteri
